{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=23", "query": { "intervention": "Intensive therapy", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 975, "total_pages": 98, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T04:02:58.096Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07510256", "title": "Effects of Breathwork and Meditation on Addiction Recovery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Addiction", "Addiction Disorders" ], "interventions": [ { "name": "SKY Breathing Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2024-11-18", "completion_date": "2025-10-02", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 1, "location_summary": "Sanborn, New York", "locations": [ { "city": "Sanborn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07510256" }, { "nct_id": "NCT02563327", "title": "Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Rifapentine", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Pyridoxine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2516, "start_date": "2016-01-25", "completion_date": "2021-08-30", "has_results": true, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02563327" }, { "nct_id": "NCT06652438", "title": "Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myeloid Leukemia, Adult" ], "interventions": [ { "name": "Revumenib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stichting Hemato-Oncologie voor Volwassenen Nederland", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 448, "start_date": "2025-05-05", "completion_date": "2032-08-27", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 14, "location_summary": "Los Angeles, California • San Francisco, California • Jacksonville, Florida + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Fairway", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06652438" }, { "nct_id": "NCT00368355", "title": "T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Non Hodgkins Lymphoma", "Myelodysplastic Syndrome", "Acute Myeloid Leukemia", "Chronic Myelogenous Leukemia", "Hemophagocytic Lymphohistiocytosis (HLH)", "Familial Hemophagocytic Lymphohistiocytosis (FLH)", "Viral-associated Hemophagocytic Syndrome (VAHS)", "X-linked Lymphoproliferative Disease (XLP)" ], "interventions": [ { "name": "Ara-C", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Campath-1H", "type": "BIOLOGICAL" }, { "name": "Total Body Irradiation", "type": "RADIATION" }, { "name": "Stem Cell Infusion", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "RADIATION", "PROCEDURE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "55 Years", "sex": "ALL", "summary": "Up to 55 Years" }, "enrollment_count": 46, "start_date": "2000-04", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2020-01-21", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00368355" }, { "nct_id": "NCT04132284", "title": "DBT-Based Parenting Intervention for Parents of Youth at Risk for Suicide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adolescent - Emotional Problem", "Suicide and Self-harm", "Parenting" ], "interventions": [ { "name": "DBT-Based Parenting Intervention", "type": "BEHAVIORAL" }, { "name": "Treatment as Usual", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 91, "start_date": "2020-07-01", "completion_date": "2023-06-16", "has_results": false, "last_update_posted_date": "2023-11-29", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04132284" }, { "nct_id": "NCT04199052", "title": "LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV/AIDS" ], "interventions": [ { "name": "LinkPositively", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2021-09-14", "completion_date": "2023-10-31", "has_results": true, "last_update_posted_date": "2025-07-03", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199052" }, { "nct_id": "NCT01721876", "title": "Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leukemia, Myeloid, Acute" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Volasertib", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 666, "start_date": "2013-01-29", "completion_date": "2021-05-28", "has_results": true, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 4, "location_summary": "Los Angeles, California • Duluth, Minnesota • Nashville, Tennessee + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Duluth", "state": "Minnesota" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01721876" }, { "nct_id": "NCT00314106", "title": "Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Melanoma" ], "interventions": [ { "name": "Melanoma Reactive TIL", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "IL-2", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "1200 total body irradiation (TBI)", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2006-04", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2012-10-18", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00314106" }, { "nct_id": "NCT03535298", "title": "Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Multiple Sclerosis, Relapsing-Remitting" ], "interventions": [ { "name": "Early Highly Effective Therapies Group", "type": "DRUG" }, { "name": "Escalation Therapies Group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 800, "start_date": "2019-01-03", "completion_date": "2027-07-30", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 15, "location_summary": "Aurora, Colorado • Minneapolis, Minnesota • Rochester, Minnesota + 11 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03535298" }, { "nct_id": "NCT00023387", "title": "TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Rifapentine", "type": "DRUG" }, { "name": "25-desacetyl Rifapentine", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2000-03", "completion_date": "2001-05", "has_results": false, "last_update_posted_date": "2005-09-13", "last_synced_at": "2026-10-26T04:02:58.096Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Los Angeles, California • San Francisco, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00023387" } ] }